Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cancer Immunotherapy & Biofluid Biopsies 2016

Abstract



The Generation of Tumor-Associated T Regulatory Cells Critically Depends on Calcineurin

Francesco Marangoni, Instructor in Medicine, Harvard Medical School

CD4+FoxP3+ T regulatory cells (Tregs) play a key role maintaining immune homeostasis, yet they are also improperly co-opted by tumors where they blunt anti-tumor immunity and facilitate progression.  Treg function is maintained in vivo by continuous triggering of the T cell receptor (TCR), yet it is unknown how interactions between Tregs and APCs in the context of tumor development dynamically trigger the TCR and the numerous signaling pathways downstream of it. Among these, the role of the calcineurin / NFAT pathway in Treg biology is controversial. We thus investigated the role of calcineurin / NFAT signaling in supporting tumor-associated Treg (TuTreg) generation and function by using mice with Treg-specific deletion of calcineurin B (CnB) and intravital imaging of NFAT activation.  In tumor-draining lymph nodes, Treg activation and the expression of chemokine receptors promoting tumor homing was completely dependent on calcineurin.  Consistently, CnB-deficient Tregs failed to infiltrate the tumor mass, whose growth was controlled. In contrast, Treg-specific deletion of the costimulatory molecule CD28 allowed a sizeable population of Tregs to infiltrate the tumor, whose progression was only partially limited.
Within the tumor mass, polyclonal TuTregs efficiently activated the calcineurin / NFAT pathway during even transient interactions with APCs, whereas polyclonal effector CD4+ cells failed to do so.  This was due to selection of a tumor-reactive TCR repertoire, because TuTregs and effector T cells bearing an identical TCR recognizing a tumor-associated antigen got comparably activated in vivo.  The functional relevance of calcineurin / NFAT activation in TuTregs is currently under investigation. Our data indicate a key role of


Add to Calendar ▼2016-11-01 00:00:002016-11-02 00:00:00Europe/LondonCancer Immunotherapy and Biofluid Biopsies 2016Cancer Immunotherapy and Biofluid Biopsies 2016 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com